Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Plenty of people want to lose weight in 2025, but here's why many may actually get there thanks to GLP-1 drugs.

Ozempic and Wegovy, made by Novo, are on track to become the world’s top-selling drugs by 2025. Yet in 2024, ‘Wegovy Wednesday’ had already become one of the biggest weight-loss trends to sweep the ...

In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could be used for in adults and children 10 and up. The new drug, sold under the ...

Every three years, a survey is conducted to find out the most significant health concerns for people who live in the area.

SHOPPING: If you're ready to meet your weight goals, turn to Hims for personalized weight loss treatments that are ...

CHAPEL HILL, N.C. (WTVD) -- Recent studies show medications like Ozempic, originally designed for type 2 diabetes and weight loss, may help people struggling with addiction. Researchers published ...

GLP-1 drugs — which include Ozempic and its sister drug Wegovy, as well as Mounjaro and Zepbound — mimic at least one hormone produced by the gut to signal fullness, leading to a reduced appetite.